Oncogene - Table of Contents alert Volume 37 Issue 32

If you are unable to see the message below, click here to view.

TABLE OF CONTENTS Volume 37, Issue 32 In this issue Review Article Article Also new AOP Review Article Pro-tumorigenic roles of fibroblast activation protein in cancer: back to the basics Ellen Puré & Rachel Blomberg Oncogene 2018 37 :4343 - 4357; May 03, 2018; 10.1038/s41388-018-0275-3 Abstract | Full Text Article DNA methyltransferase 3A isoform b contributes to repressing E-cadherin through cooperation of DNA methylation and H3K27/H3K9 methylation in EMT-related metastasis of gastric cancer He Cui, Ying Hu, Didi Guo, Aifeng Zhang, Yuejun Gu et al. Oncogene 2018 37 :4358 - 4371; May 02, 2018; 10.1038/s41388-018-0285-1 Abstract | Full Text A novel three-dimensional high-throughput screening approach identifies inducers of a mutant KRAS selective lethal phenotype Smitha Kota, Shurong Hou, William Guerrant, Franck Madoux, Scott Troutman et al. Oncogene 2018 37 :4372 - 4384; May 10, 2018; 10.1038/s41388-018-0257-5 Abstract | Full Text Antagonizing CD105 enhances radiation sensitivity in prostate cancer Anisha Madhav, Allen Andres, Frank Duong, Rajeev Mishra, Subhash Haldar et al. Oncogene 2018 37 :4385 - 4397; May 02, 2018; 10.1038/s41388-018-0278-0 Abstract | Full Text Myoferlin controls mitochondrial structure and activity in pancreatic ductal adenocarcinoma, and affects tumor aggressiveness Gilles Rademaker, Vincent Hennequière, Laura Brohée, Marie-Julie Nokin, Pierre Lovinfosse et al. Oncogene 2018 37 :4398 - 4412; May 03, 2018; 10.1038/s41388-018-0287-z Abstract | Full Text HRI-mediated translational repression reduces proteotoxicity and sensitivity to bortezomib in human pancreatic cancer cells Matthew C. White, Rebecca D. Schroeder, Keyi Zhu, Katherine Xiong & David J. McConkey Oncogene 2018 37 :4413 - 4427; May 03, 2018; 10.1038/s41388-018-0227-y Abstract | Full Text Fibroblast-derived CXCL12 promotes breast cancer metastasis by facilitating tumor cell intravasation Dinesh K. Ahirwar, Mohd W. Nasser, Madhu M. Ouseph, Mohamad Elbaz, Maria C. Cuitiño et al. Oncogene 2018 37 :4428 - 4442; May 03, 2018; 10.1038/s41388-018-0263-7 Abstract | Full Text Recapitulation of pharmacogenomic data reveals that invalidation of SULF2 enhance sorafenib susceptibility in liver cancer Sarah Yoon, Eun-Ju Lee, Ji-Hye Choi, Taek Chung, Do Young Kim et al. Oncogene 2018 37 :4443 - 4454; May 03, 2018; 10.1038/s41388-018-0291-3 Abstract | Full Text Loss-of-function of IFT88 determines metabolic phenotypes in thyroid cancer Junguee Lee, Shinae Yi, Minho Won, Young Shin Song, Hyon-Seung Yi et al. Oncogene 2018 37 :4455 - 4474; May 10, 2018; 10.1038/s41388-018-0211-6 Abstract | Full Text Dual inhibition of BCL-XL and MCL-1 is required to induce tumour regression in lung squamous cell carcinomas sensitive to FGFR inhibition Clare E. Weeden, Casey Ah-Cann, Aliaksei Z. Holik, Julie Pasquet, Jean-Marc Garnier et al. Oncogene 2018 37 :4475 - 4488; May 10, 2018; 10.1038/s41388-018-0268-2 Abstract | Full Text Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Oncogene. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Springer Nature |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Springer Nature's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW. Nature is part of Springer Nature. © 2018 Springer Nature Limited. All rights reserved.